Search research articles
Contact Us
Filters
Showing results (281-290 of 309) with videos related to
Page
of 31
Sort By:
Alzheimer'S Research & Therapy
|
September 23, 2020
Age and APOE genotype affect the relationship between objectively measured physical activity and power in the alpha band, a marker of brain disease
Jaisalmer de Frutos-Lucas, Pablo Cuesta, Federico Ramírez-Toraño, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
Azadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms
James D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy
|
November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Frontiers in Aging Neuroscience
|
March 6, 2015
Bone mineral density, adiposity, and cognitive functions
Hamid R Sohrabi, Kristyn A Bates, Michael Weinborn, et al.
Neuroimage
|
July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's disease
Vikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Nature Communications
|
November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach, Noel G Faux, Andrew D Watt, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology
|
July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer disease
James D Doecke, Simon M Laws, Noel G Faux, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 309) with videos related to
Sort By:
Page
of 31
Alzheimer'S Research & Therapy
|
September 23, 2020
Age and APOE genotype affect the relationship between objectively measured physical activity and power in the alpha band, a marker of brain disease
Jaisalmer de Frutos-Lucas, Pablo Cuesta, Federico Ramírez-Toraño, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
Azadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Journal of Alzheimer'S Disease : JAD
|
November 25, 2017
Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms
James D Doecke, Alan Rembach, Victor L Villemagne, et al.
Alzheimer'S Research & Therapy
|
November 20, 2015
Alzheimer's disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Alan Rembach, Lisbeth A Evered, Qiao-Xin Li, et al.
Frontiers in Aging Neuroscience
|
March 6, 2015
Bone mineral density, adiposity, and cognitive functions
Hamid R Sohrabi, Kristyn A Bates, Michael Weinborn, et al.
Neuroimage
|
July 22, 2025
A large-scale multi-centre study characterising atrophy heterogeneity in Alzheimer's disease
Vikram Venkatraghavan, Damiano Archetti, Pierrick Bourgeat, et al.
Nature Communications
|
November 11, 2020
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease
Kevin Huynh, Wei Ling Florence Lim, Corey Giles, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
March 16, 2013
Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease
Alan Rembach, Noel G Faux, Andrew D Watt, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Qiao-Xin Li, Victor L Villemagne, James D Doecke, et al.
Archives of Neurology
|
July 18, 2012
Blood-based protein biomarkers for diagnosis of Alzheimer disease
James D Doecke, Simon M Laws, Noel G Faux, et al.
Page
of 31